PROVIDER PROFILE · NPI 1124204375

Genevieve MacdonaldACNP

PRACTICEMAINE MEDICAL PARTNERSSee all providers at this practice →

Nurse PractitionerPortland, MEI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$2K

Peer benchmark

Total Medicare services vs. 1,197 Nurse Practitioner providers in ME — below median (cohort median 175).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$270

Distinct drugs

Brand share

20.5%

Top prescribed drugs

Clopidogrel Bisulfate18 claims

Atorvastatin Calcium17 claims

Metoprolol Tartrate15 claims

Potassium Chloride14 claims

Furosemide13 claims

QUALITY · MIPS · 2024

Final MIPS score

97.9

Quality

83.3

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.97%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 200009

Hospital

REFERRAL NETWORK

Where Genevieve Macdonald's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Michael Quinn Diagnostic Radiology · Portland, ME	13	22

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
MAINEHEALTH	22	39
NICOLOSI, ALFRED	15	53
Michael Quinn Diagnostic Radiology · Portland, ME	13	30
Sharon Siegel Diagnostic Radiology · Portland, ME	13	18

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history